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Abstract
Purpose: To retrospectively evaluate the results after a regimen of surgery, IORT (intraoperative
radiotherapy), and EBRT (external beam radiotherapy) for soft-tissue sarcomas
Methods: 38 consecutive patients underwent IORT for soft-tissue sarcoma; 29 were treated for
primary tumours, 9 for recurrences. There were 14 cases with liposarcomas, 8 with
leiomyosarcomas, 7 with malignant fibrous histiocytomas. 27/38 tumours were located in the
extremities, the remaining ones in the retroperitoneum or the chest. Radical resection was
attempted in all patients; a R0-resection was achieved in 15/38 patients, R1 in 12/38 pats and R2 in
4/38 pats. IORT was performed using a J-125 source and a HDR (high dose rate) afterloading
machine after suturing silicone flaps to the tumour bed. The total dose applied ranged from 8–15
Gy/0.5 cm tissue depth measured from the flap surface. After wound healing external beam
radiotherapy (EBRT) was applied in 31/38 patients with total doses of 23–56 Gy dependent on
resection status and wound situation. The mean duration of follow-up was 2.3 years.
Results: A local recurrence was found in 10/36 patients, lymph node metastases in 2/35, and
distant metastases in 6/35 patients. The actuarial local control rate was 63%/5 years. The overall
survival rate was 57%/5 years. There was no statistically significant difference between the results
after treatment for primaries or for recurrences. Late toxicity to the skin was found in 13/31
patients, wound healing problems in 5/31 patients. A neuropathy was never seen.
Conclusion: The combination of surgery, IORT, and EBRT yields favourable local control and
survival data which are well within the range of the results reported in the literature. The
complication rates, however, are considerable although the complications are not severe, they
should be taken into account when therapy decisions are made.
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Introduction
Intraoperative radiotherapy (IORT) is known to be a rea-
sonable therapeutic option in the treatment of soft-tissue
sarcomas especially because it enables the application of
higher total doses to the target volume than possible with
EBRT alone, or makes possible a lower EBRT target dose
with corresponding lower dose to surrounding healthy tis-
sues. A higher local dose to the tumour bed is expected to
increase the probability of local control and – at the same
time – to avoid higher toxicity rates to the healthy sur-
rounding tissues, because these can easily be removed out
of the IORT target volume [1-3].
In principle, IORT can be applied using electrons of a lin-
ear accelerator situated in the operating theatre or nearby
[4] or of special electron accelerators like Novac7™ [5] or
Mobetron™ [6]. Another possibility is the application of
brachytherapy using a Ir-192 source guided by needles or
plastic tubes within silicone flaps which are very useful to
maintain the irradiation geometry [7]. Lastly, some
French groups prefer the implantation of plastic tubes
directly into the tumour bed which allow radiotherapy by
insertion of Ir-192 sources immediately or even days after
surgery [8,9].
The purpose of this retrospective evaluation was to review
the Homburg experience with intraoperative brachyther-
apy combined with EBRT for soft-tissue sarcomas and to
compare our data with data taken from the literature.
Patients and methods
Patient characteristics
We retrospectively reviewed the data of 38 consecutive
patients who underwent IORT for soft-tissue sarcoma. 29/
38 patients were treated for primary sarcomas, in the
remaining nine the disease had recurred. The mean age at
the beginning of treatment was 56 years, the mean
Karnofsky performance status 92%. In the majority of
cases the sarcomas were located in the lower extremities or
the retroperitoneum. The most frequent histological type
was liposarcoma. The histopathological grading was pre-
dominantly G3. 30/38 tumours were classified as T2
while the subclassification in T2a or T2b was not possible
because a lot of data on this point were missing in the
older records.
Before definitive surgery followed by IORT, 19/28
patients with primaries had undergone inadequate sur-
gery (14 pats.) or neoadjuvant EBRT (1 pat), or surgery
and neoadjuvant radiotherapy (1 pat.). Three further
pediatric patients had undergone chemotherapy before
IORT: one with rhabdomyosarcoma according to the CWS
protocol, two with Ewing's sarcoma according to the
Euro-Ewing or Ewing-99 protocols, respectively.
The patients with recurrences had been pre-treated by sur-
gery (3 pats) or surgery and radiotherapy (5 pats.). One
pediatric patient suffering from an Ewing's sarcoma had
undergone surgery, radiotherapy and chemotherapy
according to the EICESS-protocol. Further details are
given in Table S1, Additional file 1.
Methods
In all patients radical resection of the tumours was
attempted. The operations were performed in the depart-
ments of general surgery, trauma surgery and orthopedics
of the Saarland University Hospital and resulted in a his-
topathologically radical resection in 15/38 pats. whereas
in 12 patients the resection ended R1 and in 4 patients R2;
in the remaining 7 patients this information was not avail-
able or could not be stated by the pathologist.
IORT was performed using a Gammamed12i™ high-dose-
rate afterloading machine (Varian Medical Systems, Haan,
Germany) with a Ir-192 source and a nominal activity of
10 Ci which was situated in a special room in direct vicin-
ity to the operation theatre. After completion of surgery, a
silicone flap (size 10 × 11 cm, in 2 patients two such flaps
combined in order to cover an area of 20 × 11 cm, thick-
ness 1 cm, containing parallel centered channels 1 cm
apart and 0,5 cm from the surface) was prepared by insert-
ing needles into the channels and connecting these to the
transfer tubes. The flap was inserted into the wound and
fixed to the tumour bed by sutures (see Fig. 1). Organs at
risk (small bowel, large bowel, nerves) and the skin edges
were kept in a safe distance. Titanium clips were fixed to
the surrounding tissue near the flap corners in order to
facilitate planning of EBRT later. X-rays were taken nor-
mally in anterior and lateral direction. The patient was
transferred to the radiotherapy room under anaesthesia,
and radiotherapy was performed there (total dose 8–15
Gy at 0.5 cm tissue depth measured from the flap surface,
Status after tumour resection in the lower limb, flap in posi- tion, sciatic nerve distanced Figure 1
Status after tumour resection in the lower limb, flap 
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duration of therapy 15–48 minutes depending on dose,
area to be covered, and the activity of the source on that
day). In the meantime, the anesthesist monitored the
patient by a camera and telemetry devices. After comple-
tion of radiotherapy, the patient was taken back to the
operating theatre, x-rays were taken again in order to
exclude dislocation of the flap, the flap was removed, and
the wound was closed.
EBRT was intended in all patients not irradiated before,
with a planned dose of 50 Gy if R0 and 56 Gy if R1 resec-
tion. Vacuum positioning devices were used regularly,
mostly a 3-D therapy plan was performed based on the CT
in therapy position combined with the radiographs taken
in the operating theatre. For treatment we applied 6 MV X-
rays of a linear accelerator.
In fact, 31/38 patients received EBRT with total doses
ranging from 23–56 Gy afterwards, while the time interval
between IORT and EBRT amounted to a mean of 33 (13–
102) days depending on the wound healing process. The
remaining 7 patients had either been irradiated neoadju-
vantly (2 patients) or during therapy of the former pri-
mary tumour (5 patients).
The first follow-up examination was performed 6–8 weeks
after completion of radiotherapy and then in 3 – 12
months' intervals. Regularly, a clinical examination was
performed followed by ultrasound, CT or MRT. Chest X-
rays were intended yearly. Force and function of the
affected extremity were not recorded regularly. Overall,
the data concerning toxicity were rather rare so that only
late skin toxicity and delayed wound healing can be
reported here.
The mean duration of follow-up was 2.3 years (0.1–10
years).
Further details are given in Table S1, Additional file 1.
All data were entered into a special medical database
(MEDLOG, Parox Comp., Muenster, Germany). If follow-
up data were missing written questionnaires were sent to
the patients' doctors and the local authorities. Means,
absolute and relative frequencies were computed. Survival
curves were obtained using the Kaplan-Meier estimate and
were compared using the Mantel-Haensel test. The search
for prognostic factors was performed univariately using
Spearman's rho and Kendall's tau tests as well as multivar-
iately using the Cox regression hazard model.
All patients had given their written informed consent
before radiotherapy. An approval by the local ethics com-
mittee was not necessary due to the retrospective evalua-
tion. The research carried out here is in compliance with
the declaration of Helsinki.
Results
During follow-up a local recurrence was diagnosed in 10/
36 patients in which sufficient data on this point could be
obtained. Among the seven patients with recurrences and
sufficient data, the surgical result was R2 in two, R1 in
three and R0 only in 2 patients whereas among the 23
patients without a recurrence the result was R2 in two, R1
in eight and R0 in 13 patients (p = 0.0766 chi-square test).
Lymph node metastases were found in only 2/35 and dis-
tant metastases in 6/35 patients with sufficient data. In
four patients, lung metastases were diagnosed, in the
remaining two liver, peritoneal and lymph node metas-
tases were found. There was no significant difference
between the patients treated for a primary or for a recur-
rence. The actuarial local control was 63%/5 years.
At the end of follow-up (mean duration: 2.3 years) 12
patients had died, 25 were known to be alive, the survival
status of the remaining patient was unclear. The overall
survival probability amounted to 67%/2 years and to
57%/5 years (Fig. 2). The actuarial local control rate was
64%/5 years (Fig. 3). Using the Kaplan-Meier estimate,
the curve for the patients with relapses seemed to be
slightly inferior to that for the patients with primaries, a
statistically significant difference could not be found,
which may additionally be due to the limited number of
patients in the second group.
Acute gastrointestinal toxicity was rare and mild (only in
3/38 patients). Toxicity to the skin after IORT and EBRT
was found as follows: no toxicity in 16/37 pats., grade I
Overall survival vs. time (Kaplan-Meier-Estimate) Figure 2
Overall survival vs. time (Kaplan-Meier-Estimate).Radiation Oncology 2009, 4:32 http://www.ro-journal.com/content/4/1/32
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WHO in 8/33 pats., grade II WHO in two patients, and
grade III WHO in 11/37 pats, whereas the higher grades of
skin toxicity were found in patients with sarcomas of the
extremities. Long-term side effects to the skin were found
as follows: no toxicity in 18/31 pats., grade 1 EORTC in
11/31 and grade II EORTC in 2/31 patients. Patients with
more intense acute side effects experienced long-term side
effects more frequently and intensely (Spearman's rho,
Kendall's tau, p = 0.045/0.009).
Severe wound healing problems were found in five
patients with sarcomas of the extremities, one of them suf-
fering from a small fistula in the scar, in a further three
limb edema was diagnosed. Further data concerning force
and function of the involved extremity are not available.
We never were aware of a neuropathy.
Significant prognostic factors could be found neither uni-
variately nor multivariately. This may be due to the small
number of patients and consequently events during fol-
low-up.
Further details are given in Table S2, Additional file 2.
Discussion
One of the pioneers in IORT were Abe et al. working in
Kyoto, Japan, who reported the method and preliminary
results of application of Co-60 and electron beams
directly to the tumour in the late sixties and early seventies
of the last century. The authors applied IORT mainly to
the stomach, the pancreas and the colon. To our knowl-
edge, the first case report of IORT for soft-tissue sarcoma
appeared in 1973 [10]. The method has been reported in
more detail in 1975 [11] where the first ten cases of soft
tissue sarcoma were evaluated; this collective was reana-
lyzed in 1980 [12]. In the meantime numerous retrospec-
tive papers were published on the subject (see Table S3,
Additional file 3). The majority of author groups show
that very favourable results can be obtained by a regimen
of surgery, IORT, and EBRT. However, randomized trials
comparing this therapy regimen to the standard (surgery
followed by EBRT) are rare, trials comparing the two
methods of IORT (flaps versus electron fields) are still
lacking.
The majority of authors report about the intraoperative
application of electrons [11-32]. While Abe et al. tried to
control the tumour by IORT alone applying doses ranging
from 30–45 Gy [11,12], the authors of more recent papers
preferred the combination of IORT as an early boost with
a highly conformal external beam radiotherapy. In this
setting electron doses of 7.5 – 25 Gy were combined with
doses ranging from 36 to 60 Gy applied percutaneously.
The results were remarkable, the author groups show local
control rates ranging from 40 to 100%/5 years resulting in
overall survival data ranging from 45–84%/5 years.
Acute and long-term side effects are frequently reported.
Mostly wound healing problems, gastrointestinal side
effects and neuropathies are stated with the frequency of
those ranging from 5 to more than 50% of the patients.
11 author groups reported about IORT using brachyther-
apy [8,9,22,33-40]. Typical flap techniques as described
above were used by seven author groups, the remaining
four applied "intraoperative implants" (2), ribbons (1)
and tubes in a mesh (1). The doses applied ranged from 8
to 34 Gy in 0.5 or 1.0 cm distance from the applicator sur-
face. EBRT doses of 0 – 50 Gy were added. The results were
encouraging and within the same range as the electron
results. The local control probability was found to be in
the range 62–89%/5 years whereas the overall survival
was 45–82%/5 years. The complication rate was consider-
able. Wound healing problems in 30–40% were stated,
late complications in general in 24–44% of the patients.
Two author groups utilized 100 kV [17] or 250 kV [41]
orthovoltage beams applying total doses of 6–25 Gy fol-
lowed by an EBRT with total doses of 31–50 Gy and
recorded similar results.
Our results fit well to the literature data, having achieved
a local control rate of 63%/5 years and an overall survival
of 57%/5 years with a late complication rate of 42% com-
prising delayed wound healing and late skin reactions, but
neuropathy was never observed.
Local recurrence-free survival (Kaplan-Meier-Estimate) Figure 3
Local recurrence-free survival (Kaplan-Meier-Esti-
mate).Radiation Oncology 2009, 4:32 http://www.ro-journal.com/content/4/1/32
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To our knowledge the only randomized study was con-
ducted by Sindelar et al. [27]. The authors compared the
effects of IORT + EBRT to those of EBRT alone after surgery
for retroperitoneal sarcomas. They found an impressive
but nevertheless insignificant gain of local control (but
not of survival) after IORT + EBRT, the local complica-
tions were significantly increased after EBRT alone com-
pared to IORT + EBRT (further details are given in Table
S3, Additional file 3).
According to a patterns-of-care study conducted by Kaiser
et al [42] at least 24 centres in Germany are working regu-
larly with IORT, among these are 16 universities. 11 cent-
ers use linear accelerators, 15 perform brachytherapy. In
the majority of cases IORT is prescribed for gastric, pancre-
atic, bile duct and rectal cancers as well as for soft-tissue
and bone sarcomas. The total dose applied by IORT varies
between 10 and 25 Gy.
Conclusion
Our data and those taken from the literature show that
soft-tissue sarcomas can be reasonably and successfully
treated by radical surgery and a combination of brachy-
therapy IORT and EBRT. However, it should be born in
mind that acute and late complication rates may be ele-
vated by adding IORT to the therapy protocol whereas the
evidence that this combination may be superior to surgery
and EBRT alone concerning local control and survival is
still limited
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